EcoDrugPlus

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSPFOG00000017754
Gene Symbol: LOC103130771
3 Cross references
209 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSPFOG00000009188
Gene Symbol: PRKCB
4 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSPFOG00000000695
Gene Symbol: LOC103129836
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSPFOG00000001747
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSPFOG00000010318
Gene Symbol: PRKCE
2 Cross references
249 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSPFOG00000001134
Gene Symbol: PRKCE
2 Cross references
245 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSPFOG00000008240
Gene Symbol: PRKCH
3 Cross references
224 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSPFOG00000005126
Gene Symbol: PRKCI
3 Cross references
87 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSPFOG00000004121
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSPFOG00000013625
Gene Symbol: PRKCAA
1 Cross references
213 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSPFOG00000003197
Gene Symbol: PRKCDA
1 Cross references
204 Possible Orthologues:

Protein Kinase C, Zeta

Ensembl ID : ENSPFOG00000014668
Gene Symbol: PRKCZ
1 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).